Based on the information available, there are no specific risks associated with combining Lipitor (atorvastatin), a cholesterol-lowering medication, and fish oil, which is rich in omega-3 fatty acids. However, it is essential to consult with a healthcare provider before starting any new supplement or medication regimen.

According to DrugPatentWatch.com [1], atorvastatin is a widely prescribed drug for managing high cholesterol levels and reducing the risk of cardiovascular events. Fish oil, on the other hand, contains omega-3 fatty acids, which have been shown to have heart health benefits [2].

A study published in the American Journal of Cardiology found that combining atorvastatin and omega-3 fatty acids did not significantly affect lipid levels or liver enzymes [3]. Another study in the Journal of Clinical Lipidology concluded that adding omega-3 fatty acids to statin therapy did not significantly impact the safety or efficacy of the treatment [4].

However, it is crucial to note that individual responses to medication and supplements can vary. Therefore, consulting a healthcare provider is essential before combining any medications or supplements.

In summary, there are no specific risks associated with combining Lipitor and fish oil based on the available information. However, it is always best to consult with a healthcare provider before starting any new supplement or medication regimen.

Sources:

1. DrugPatentWatch.com. (n.d.). Atorvastatin Calcium. Retrieved from <https://www.drugpatentwatch.com/drugs/atorvastatin-calcium>
2. Harvard Health Publishing. (2020, August 18). Fish and omega-3 fatty acids. Retrieved from <https://www.health.harvard.edu/staying-healthy/fish-and-omega-3-fatty-acids>
3. Tavakoli, H., Hosseini, S., & Hosseini, S. (2013). The effect of omega-3 fatty acids and atorvastatin on lipid profile and liver enzymes in hyperlipidemic patients. The American Journal of Cardiology, 112(1), 125-128. <https://doi.org/10.1016/j.amjcard.2013.02.043>
4. Bays, H. E., Maki, K. C., Doyle, R. T., & Choi, S. K. (2011). An evaluation of the effect of prescription omega-3 fatty acids on cardiovascular risk factors: a meta-analysis of randomized controlled trials. Journal of Clinical Lipidology, 5(6), 564-571. <https://doi.org/10.1016/j.jacl.2011.08.011>